Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01328
|
|||||
Drug Name |
Benztropine
|
|||||
Synonyms |
benztropine; Benzatropine; Tropine benzohydryl ether; Benzatropinum; Benzatropina; Cogentin; Cogentinol; 3endo-benzhydryloxytropane; UNII-1NHL2J4X8K; Benztropinum; Cogentine; Cobrentin; Akitan; 3alpha-(diphenylmethoxy)tropane; HSDB 3014; NK 02; 1NHL2J4X8K; Benzatropinum [INN-Latin]; Benzatropina [INN-Spanish]; 3alpha-(Diphenylmethoxy)-1alphaH,5alphaH-tropane; 3alpha-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane; NCGC00159471-02; (3-endo)-3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Parkinson's Disease [ICD11: 8A00.0] | Approved | [1] | |||
Dystonia [ICD11: 8A02] | Approved | [1] | ||||
Therapeutic Class |
Antiparkinson Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C21H25NO
|
|||||
Canonical SMILES |
CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4
|
|||||
InChI |
InChI=1S/C21H25NO/c1-22-18-12-13-19(22)15-20(14-18)23-21(16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18-21H,12-15H2,1H3/t18-,19+,20?
|
|||||
InChIKey |
GIJXKZJWITVLHI-YOFSQIOKSA-N
|
|||||
CAS Number |
CAS 86-13-5
|
|||||
Pharmaceutical Properties | Molecular Weight | 307.4 | Topological Polar Surface Area | 12.5 | ||
Heavy Atom Count | 23 | Rotatable Bond Count | 4 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | |||
XLogP |
4.5
|
|||||
PubChem CID | ||||||
PubChem SID | ||||||
ChEBI ID |
CHEBI:3048
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | DAT1 | Transporter Info | Sodium-dependent dopamine transporter | Substrate | [2] | |
References | ||||||
1 | Benztropine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Pharmacological characterization of a dopamine transporter ligand that functions as a cocaine antagonist. J Pharmacol Exp Ther. 2014 Jan;348(1):106-15. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.